There have been continuous studies reporting neuronal GFAP expression during the progression of neurological diseases [46, 57]; for example, distinct GFAP splice forms expressed in pyramidal neurons of the hippocampus were identified in the brain tissues of AD patients [46]. This evidence concerns the gene GFAP and Alzheimer disease.